Toronto-based Neural Therapeutics (CSE: NURL) announced on Thursday a twofold milestone, with both the completion of a C$518,500 capital raise and the receipt of formal permission from the Canadian Securities Exchange to begin listing its shares for trading, another sign that the international psychedelics industry is making slow but steady…
Please login to read all 194 words.
